| Name | NPC1-like 1 |
| Description | The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNiemann‐Pick C1‐Like 1 (NPC1L1) is a multitransmembrane protein that plays a central role in whole‐body cholesterol homeostasis. It is prominently expressed on the apical brush border of intestinal enterocytes and in hepatocytes where it mediates the uptake of dietary and biliary cholesterol, thereby contributing critically to plasma low‐density lipoprotein levels and overall lipoprotein metabolism. Its discovery as the molecular target of ezetimibe has provided a mechanistic basis for a new cholesterol‐lowering strategy, since blocking NPC1L1 function substantially reduces intestinal cholesterol absorption."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, NPC1L1 binds cholesterol via its amino‐terminal domain and facilitates its internalization through a clathrin/AP2‐dependent endocytic pathway. Numerous studies have demonstrated that inhibition of NPC1L1 internalization—either through genetic mutations that impair its recycling or via pharmacological blockade by ezetimibe—results in reduced cholesterol uptake. The protein’s regulated trafficking involves association with microfilaments and other key proteins (for example, flotillins), and its proper glycosylation, recycling, and dimerization are essential for efficient cholesterol transport. Moreover, mutations within critical extracellular loops or in sterol‐sensing regions significantly modulate its function and are linked to variable responsiveness to ezetimibe and alterations in plasma LDL‐cholesterol levels."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in cholesterol uptake, NPC1L1 has been implicated in the intestinal absorption of other lipophilic molecules such as fat‐soluble vitamins – notably vitamin E and vitamin K – and even certain carotenoids, although it does not appear to mediate all such substrates equally. Moreover, by influencing cholesterol re‐absorption in the liver, NPC1L1 contributes to biliary cholesterol homeostasis and has been associated with conditions ranging from coronary heart disease to gallstone formation. Notably, its function has extended into studies of viral infections, where NPC1L1 has been shown to facilitate the cell-to-cell spread of hepatitis C virus, highlighting its broader impact on human pathology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic variation in NPC1L1, including both common and rare non‐synonymous alleles, has been shown to influence cholesterol absorption efficiency, modulate plasma LDL‐cholesterol levels, and affect therapeutic responses to lipid‐lowering regimens. Recent structural studies, including cryo-electron microscopy analyses, have revealed that NPC1L1 functions as a homodimer with specific transmembrane and sterol-sensing domains necessary for substrate transfer. In addition, the transcriptional regulation of NPC1L1 by factors such as SREBP2, HNF4α, and PPARα has been elucidated, providing insight into its dynamic response to metabolic cues and dietary cholesterol. These findings collectively underscore the physiological and clinical relevance of NPC1L1 as a target for both pharmacological intervention and precision medicine strategies addressing dyslipidemia and related disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Scott W Altmann, Harry R Davis, Li-Ji Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1093131"}], "href": "https://doi.org/10.1126/science.1093131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14976318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14976318"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Joanna P Davies, Catherine Scott, Kimihiko Oishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M409110200"}], "href": "https://doi.org/10.1074/jbc.M409110200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15671032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15671032"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Robert A Hegele, Justin Guy, Matthew R Ban, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lipids Health Dis (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-511X-4-16"}], "href": "https://doi.org/10.1186/1476-511X-4-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16098225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16098225"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jason S Simon, Maha C Karnoub, David J Devlin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genomics (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ygeno.2005.08.007"}], "href": "https://doi.org/10.1016/j.ygeno.2005.08.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16297596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16297596"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jonathan C Cohen, Alexander Pertsemlidis, Saleemah Fahmi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0508483103"}], "href": "https://doi.org/10.1073/pnas.0508483103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16449388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16449388"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "S Lally, C Y Tan, D Owens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-006-0177-8"}], "href": "https://doi.org/10.1007/s00125-006-0177-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16518588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16518588"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Alain Théophile Sané, Daniel Sinnett, Edgard Delvin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Localization and role of NPC1L1 in cholesterol absorption in human intestine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.M600174-JLR200"}], "href": "https://doi.org/10.1194/jlr.M600174-JLR200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16829661"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16829661"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ryan E Temel, Weiqing Tang, Yinyan Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI30060"}], "href": "https://doi.org/10.1172/JCI30060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17571164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17571164"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Dick C Chan, Gerald F Watts, Jian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2265.2007.03144.x"}], "href": "https://doi.org/10.1111/j.1365-2265.2007.03144.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18031309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18031309"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yuki Iwayanagi, Tappei Takada, Hiroshi Suzuki "}, {"type": "b", "children": [{"type": "t", "text": "HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharm Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11095-007-9496-9"}], "href": "https://doi.org/10.1007/s11095-007-9496-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18080173"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18080173"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ta-Yuan Chang, Catherine Chang "}, {"type": "b", "children": [{"type": "t", "text": "Ezetimibe blocks internalization of the NPC1L1/cholesterol complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2008.05.001"}], "href": "https://doi.org/10.1016/j.cmet.2008.05.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18522826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18522826"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Liang Ge, Jing Wang, Wei Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2008.04.001"}], "href": "https://doi.org/10.1016/j.cmet.2008.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18522832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18522832"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Myriam Moussa, Jean-François Landrier, Emmanuelle Reboul, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Nutr (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jn/138.8.1432"}], "href": "https://doi.org/10.1093/jn/138.8.1432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18641187"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18641187"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Iwona Rudkowska, Suhad S AbuMweis, Catherine Nicolle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between non-responsiveness to plant sterol intervention and polymorphisms in cholesterol metabolism genes: a case-control study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Physiol Nutr Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1139/H08-041"}], "href": "https://doi.org/10.1139/H08-041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18641716"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18641716"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Silvia Zúñiga, Héctor Molina, Lorena Azocar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ezetimibe prevents cholesterol gallstone formation in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1478-3231.2008.01808.x"}], "href": "https://doi.org/10.1111/j.1478-3231.2008.01808.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18783541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18783541"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Hai L Zhao, Adrielle H Houweling, Catherine A Vanstone, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lipids (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11745-008-3241-y"}], "href": "https://doi.org/10.1007/s11745-008-3241-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18850127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18850127"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Zhao-Yan Jiang, Chong-Yi Jiang, Lei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2008.11.131"}], "href": "https://doi.org/10.1016/j.bbrc.2008.11.131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19071091"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19071091"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jiang Wang, Bei-Bei Chu, Liang Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.M800669-JLR200"}], "href": "https://doi.org/10.1194/jlr.M800669-JLR200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19325169"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19325169"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Eliana Polisecki, Inga Peter, Jason S Simon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.P001172"}], "href": "https://doi.org/10.1194/jlr.P001172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19752398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19752398"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yoshihide Yamanashi, Tappei Takada, Hiroshi Suzuki "}, {"type": "b", "children": [{"type": "t", "text": "In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3283327925"}], "href": "https://doi.org/10.1097/FPC.0b013e3283327925"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19823104"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19823104"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Munechika Enjoji, Kazuyuki Machida, Motoyuki Kohjima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lipids Health Dis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-511X-9-29"}], "href": "https://doi.org/10.1186/1476-511X-9-29"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20222991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20222991"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Camilla Pramfalk, Zhao-Yan Jiang, Qu Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.M900274"}], "href": "https://doi.org/10.1194/jlr.M900274"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20460578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20460578"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tanya M Teslovich, Kiran Musunuru, Albert V Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biological, clinical and population relevance of 95 loci for blood lipids."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature09270"}], "href": "https://doi.org/10.1038/nature09270"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20686565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20686565"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yuki Iwayanagi, Tappei Takada, Fumiya Tomura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human NPC1L1 expression is positively regulated by PPARα."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharm Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11095-010-0294-4"}], "href": "https://doi.org/10.1007/s11095-010-0294-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20953676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20953676"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Liang Ge, Wei Qi, Li-Juan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1014434108"}], "href": "https://doi.org/10.1073/pnas.1014434108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21187433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21187433"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Li-Juan Wang, Jing Wang, Na Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.178368"}], "href": "https://doi.org/10.1074/jbc.M110.178368"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21189420"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21189420"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Hyock Joo Kwon, Maya Palnitkar, Johann Deisenhofer "}, {"type": "b", "children": [{"type": "t", "text": "The structure of the NPC1L1 N-terminal domain in a closed conformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0018722"}], "href": "https://doi.org/10.1371/journal.pone.0018722"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21525977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21525977"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jin-Hui Zhang, Liang Ge, Wei Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.244475"}], "href": "https://doi.org/10.1074/jbc.M111.244475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21602275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21602275"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Weiqing Tang, Lin Jia, Yinyan Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbalip.2011.05.013"}], "href": "https://doi.org/10.1016/j.bbalip.2011.05.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21683156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21683156"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Yoshihide Yamanashi, Tappei Takada, Jun-Ichi Shoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel function of Niemann-Pick C1-like 1 as a negative regulator of Niemann-Pick C2 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.24772"}], "href": "https://doi.org/10.1002/hep.24772"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22095670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22095670"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yuki Sato, Risa Suzuki, Masaki Kobayashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharm Pharm Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18433/j38k56"}], "href": "https://doi.org/10.18433/j38k56"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22579005"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22579005"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Naina Barretto, Bruno Sainz, Snawar Hussain, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.03241-13"}], "href": "https://doi.org/10.1128/JVI.03241-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24554660"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24554660"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Naoe Nakasone, Yuko S Nakamura, Katsumi Higaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endoplasmic reticulum-associated degradation of Niemann-Pick C1: evidence for the role of heat shock proteins and identification of lysine residues that accept ubiquitin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.549915"}], "href": "https://doi.org/10.1074/jbc.M114.549915"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24891511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24891511"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Jian Wei, Zhen-Yan Fu, Pei-Shan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The clathrin adaptor proteins ARH, Dab2, and numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.593764"}], "href": "https://doi.org/10.1074/jbc.M114.593764"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25331956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25331956"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Nathan O Stitziel, Hong-Hee Won, Alanna C Morrison, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivating mutations in NPC1L1 and protection from coronary heart disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1405386"}], "href": "https://doi.org/10.1056/NEJMoa1405386"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25390462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25390462"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Tappei Takada, Yoshihide Yamanashi, Kentaro Konishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.3010329"}], "href": "https://doi.org/10.1126/scitranslmed.3010329"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25696002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25696002"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Brian A Ference, Faisal Majeed, Raju Penumetcha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Coll Cardiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacc.2015.02.020"}], "href": "https://doi.org/10.1016/j.jacc.2015.02.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25770315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25770315"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Bo Kobberø Lauridsen, Stefan Stender, Ruth Frikke-Schmidt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Heart J (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/eurheartj/ehv108"}], "href": "https://doi.org/10.1093/eurheartj/ehv108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25841872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25841872"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Luca A Lotta, Stephen J Sharp, Stephen Burgess, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jama.2016.14568"}], "href": "https://doi.org/10.1001/jama.2016.14568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27701660"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27701660"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Piyali Saha, Justin L Shumate, Jenna G Caldwell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.57089"}], "href": "https://doi.org/10.7554/eLife.57089"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32410728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32410728"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Tao Long, Yang Liu, Yu Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structures of dimeric human NPC1L1 provide insight into mechanisms for cholesterol absorption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Adv (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/sciadv.abh3997"}], "href": "https://doi.org/10.1126/sciadv.abh3997"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34407950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34407950"}]}]}]}
|
| Synonyms | LDLCQ7, NPC11L1, SLC65A2 |
| Proteins | NPCL1_HUMAN |
| NCBI Gene ID | 29881 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NPC1L1 has 5,397 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 115 datasets.
Click the + buttons to view associations for NPC1L1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NPC1L1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NPC1L1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NPC1L1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NPC1L1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NPC1L1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NPC1L1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NPC1L1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NPC1L1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NPC1L1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NPC1L1 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NPC1L1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NPC1L1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NPC1L1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with NPC1L1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NPC1L1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NPC1L1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NPC1L1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NPC1L1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NPC1L1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NPC1L1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NPC1L1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NPC1L1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NPC1L1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NPC1L1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with NPC1L1 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NPC1L1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for NPC1L1 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NPC1L1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NPC1L1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NPC1L1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NPC1L1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NPC1L1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for NPC1L1 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NPC1L1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NPC1L1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NPC1L1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NPC1L1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NPC1L1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NPC1L1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NPC1L1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NPC1L1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NPC1L1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NPC1L1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NPC1L1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NPC1L1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NPC1L1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NPC1L1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NPC1L1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NPC1L1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NPC1L1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NPC1L1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NPC1L1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NPC1L1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NPC1L1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NPC1L1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NPC1L1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding NPC1L1 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with NPC1L1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NPC1L1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NPC1L1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NPC1L1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NPC1L1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for NPC1L1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NPC1L1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NPC1L1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NPC1L1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NPC1L1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NPC1L1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NPC1L1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NPC1L1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving NPC1L1 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NPC1L1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NPC1L1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NPC1L1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NPC1L1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NPC1L1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NPC1L1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing NPC1L1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NPC1L1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NPC1L1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NPC1L1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NPC1L1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NPC1L1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NPC1L1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with NPC1L1 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NPC1L1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NPC1L1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NPC1L1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NPC1L1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NPC1L1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving NPC1L1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving NPC1L1 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NPC1L1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NPC1L1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NPC1L1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NPC1L1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NPC1L1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NPC1L1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NPC1L1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NPC1L1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NPC1L1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NPC1L1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NPC1L1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NPC1L1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NPC1L1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NPC1L1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NPC1L1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving NPC1L1 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving NPC1L1 protein from the WikiPathways Pathways 2024 dataset. | |